EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Ectopic ACTH syndrome presenting as refractory hypokalemia in metastatic castration-resistant prostate cancer with neuroendocrine transformation

Minghan Shi, Armin Farahvash, Prashant A Jani, Shereen Aly, Joseph C Del Paggio

European Journal of Case Reports in Internal Medicine · 19.10.2026 · 13 (11)

DOI: 10.12890/2026_007396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Case Reports in Internal Medicine, online erschienen am 19.10.2026. Verfasst von Minghan Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: NOSM University, Thunder Bay, Ontario, Canada. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ectopic adrenocorticotropic hormone (ACTH) syndrome resulting from neuroendocrine transformation of prostate adenocarcinoma may present with refractory hypokalemia as an initial manifestation. Because hypokalemia is often attributed to other more common aetiologies, the diagnosis is often overlooked, leading to delayed management. A 62-year-old man with metastatic castration-resistant prostate cancer (mCRPC) with neuroendocrine transformation presented with persistent hypokalemia. He later developed severe hypokalemia, metabolic alkalosis, and hypertension with disease progression. Endocrine workup revealed markedly elevated cortisol, no suppression on low dose dexamethasone testing, and elevated ACTH. Imaging showed no pituitary or adrenal lesions but demonstrated progression of metastatic disease. These findings supported ectopic ACTH secretion secondary to neuroendocrine transformation. Before initiation of the appropriate treatment, he developed supraventricular tachycardia, hypotension, pulmonary edema, and died. This case underscores the importance of considering paraneoplastic endocrine syndromes, such as ectopic ACTH secretion, in patients with malignancies and unexplained or refractory electrolyte disturbances—particularly in the context of neuroendocrine transformation.

Schlagwörter

Stichwörter der Autor:innen

Neuroendocrine neoplasmectopic ACTH syndromehypokalemiaprostate cancer

Autor:innen und Institutionen

  • NOSM University, Thunder Bay, Ontario, Canada.
  • Department of Internal Medicine, Thunder Bay Regional Health Sciences Centre, Thunder Bay, Canada.
  • Department of Pathology, Thunder Bay Regional Health Sciences Centre, Thunder Bay, Canada.
  • Department of Medical Oncology, Thunder Bay Regional Health Sciences Centre, Thunder Bay, Canada.

Zitieren

APA

Shi, M., Farahvash, A., Jani, P. A., Aly, S., & Del Paggio, J. C. (2026). Ectopic ACTH syndrome presenting as refractory hypokalemia in metastatic castration-resistant prostate cancer with neuroendocrine transformation. European Journal of Case Reports in Internal Medicine, 13(11). https://doi.org/10.12890/2026_007396

Vancouver

Shi M, Farahvash A, Jani PA, Aly S, Del Paggio JC. Ectopic ACTH syndrome presenting as refractory hypokalemia in metastatic castration-resistant prostate cancer with neuroendocrine transformation. European Journal of Case Reports in Internal Medicine. 2026;13(11). doi:10.12890/2026_007396

BibTeX
@article{Shi2026,
  author = {Shi, Minghan and Farahvash, Armin and Jani, Prashant A and Aly, Shereen and Del Paggio, Joseph C},
  title = {Ectopic ACTH syndrome presenting as refractory hypokalemia in metastatic castration-resistant prostate cancer with neuroendocrine transformation},
  journal = {European Journal of Case Reports in Internal Medicine},
  year = {2026},
  volume = {13},
  number = {11},
  doi = {10.12890/2026_007396}
}
Kostenlos starten →